{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:34Z","timestamp":1787008774777,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3606500"],"award-info":[{"award-number":["2023YFC3606500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602400"],"award-info":[{"award-number":["2022YFC3602400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602401"],"award-info":[{"award-number":["2022YFC3602401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500602"],"award-info":[{"award-number":["2021YFC2500602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170437"],"award-info":[{"award-number":["82170437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Provincial Natural Science Foundation of Hunan","doi-asserted-by":"publisher","award":["2024JJ8118"],"award-info":[{"award-number":["2024JJ8118"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012486","name":"Central South University Innovation-Driven Research Program","doi-asserted-by":"publisher","award":["2023CXQD007"],"award-info":[{"award-number":["2023CXQD007"]}],"id":[{"id":"10.13039\/501100012486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Whether polycystic ovary syndrome (PCOS) is an independent risk factor for long-term cardiovascular disease (CVD) is unclear, and the risk of CVD in easily overlooked young nonobese PCOS patients is unknown. This study aimed to investigate the associations of PCOS with CVD and identify the management priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Three thousand and eight hundred sixty-four participants (645 with PCOS) from UK Biobank were recruited from 2006 to 2010. The cumulative incidences of the CVD were calculated and compared between patients with and without PCOS via the log-rank test. Cox proportional risk regression models were used to assess the relationships of PCOS with CVD and the impact of PCOS treatments on CVD risk. Polygenic risk scores and linkage disequilibrium score regression were used to assess the genetic-level associations. Then, proteomics subgroup cohort was conducted to explore the significant biomarker involved in the PCOS\u2013CVD associations. Compared with participants without PCOS, participants with PCOS had greater risks of CVD [hazard ratio (HR) = 1.77, 95% confidence interval (CI) = 1.19\u20132.65], coronary artery disease (HR = 2.27, 95% CI = 1.35\u20133.81), and myocardial infarction (HR = 2.08, 95% CI = 1.11\u20133.90) independent of genetic risk, especially for young nonobese PCOS patients (Pfor interaction &amp;lt; 0.05). Current commonly used treatments did not affect CVD incidence. Proteomics cohort revealed that discoidin, CUB, and LCCL domain-containing protein 2 (DCBLD2) may be specific CVD biomarker for patients with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with PCOS had an increased risk of CVD, and young nonobese PCOS patients should be prioritized for CVD risk management. These findings support the necessity of clinical surveillance and suggest DCBLD2 as a possible CVD biomarker in females with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwae375","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T07:15:41Z","timestamp":1731827741000},"source":"Crossref","is-referenced-by-count":3,"title":["Nonobese young females with polycystic ovary syndrome are at high risk for long-term cardiovascular disease"],"prefix":"10.1093","author":[{"given":"Xingping","family":"Zhao","sequence":"first","affiliation":[{"name":"Clinical Research Center, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]},{"name":"Department of Gynecology, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]},{"name":"Department of Cardiology, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]},{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Guangxi Medical University , Nanning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5486-763X","authenticated-orcid":false,"given":"Dabao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-7870","authenticated-orcid":false,"given":"Yao","family":"Lu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]},{"name":"Department of Cardiology, The Third Xiangya Hospital of Central South University , 138 Tongzipo Road, Changsha, Hunan 410013 ,","place":["China"]},{"name":"Faculty of Life Sciences & Medicine, King\u2019s College London , 150 Stamford Street, London SE1 9NH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"2024120321073193800_zwae375-B1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"2024120321073193800_zwae375-B2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/humrep\/dead053","article-title":"Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis","volume":"38","author":"Dobbie","year":"2023","journal-title":"Hum Reprod"},{"key":"2024120321073193800_zwae375-B3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"2024120321073193800_zwae375-B4","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024120321073193800_zwae375-B5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"key":"2024120321073193800_zwae375-B6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril"},{"key":"2024120321073193800_zwae375-B7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2024120321073193800_zwae375-B8","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.3390\/nu13103526","article-title":"Dietary intake, eating behavior, physical activity, and quality of life in infertile women with PCOS and obesity compared with non-PCOS obese controls","volume":"13","author":"Wang","year":"2021","journal-title":"Nutrients"},{"key":"2024120321073193800_zwae375-B9","doi-asserted-by":"crossref","first-page":"808898","DOI":"10.3389\/fendo.2022.808898","article-title":"Life modifications and PCOS: old story but new tales","volume":"13","author":"Gu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024120321073193800_zwae375-B10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/09513590903247816","article-title":"Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome","volume":"26","author":"Arikan","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"2024120321073193800_zwae375-B11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","article-title":"Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters","volume":"40","author":"Durmus","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2024120321073193800_zwae375-B12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2024120321073193800_zwae375-B13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mcna.2021.06.008","article-title":"Practical approach to hyperandrogenism in women","volume":"105","author":"Sharma","year":"2021","journal-title":"Med Clin North Am"},{"key":"2024120321073193800_zwae375-B14","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/clinem\/dgaa605","article-title":"Sustained maternal hyperandrogenism during PCOS pregnancy reduced by metformin in non-obese women carrying a male fetus","volume":"105","author":"Andr\u00e6","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024120321073193800_zwae375-B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"2024120321073193800_zwae375-B16","doi-asserted-by":"publisher","author":"Thompson","DOI":"10.1101\/2022.06.16.22276246"},{"key":"2024120321073193800_zwae375-B17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2024120321073193800_zwae375-B18","first-page":"1560","article-title":"Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome","volume":"31","author":"Wan","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2024120321073193800_zwae375-B19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"key":"2024120321073193800_zwae375-B20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2024120321073193800_zwae375-B21","first-page":"74","article-title":"Risk of cardiovascular events in patients with polycystic ovary syndrome","volume":"70","author":"Iftikhar","year":"2012","journal-title":"Neth J Med"},{"key":"2024120321073193800_zwae375-B22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"2024120321073193800_zwae375-B23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2024120321073193800_zwae375-B24","doi-asserted-by":"crossref","first-page":"1179558119874042","DOI":"10.1177\/1179558119874042","article-title":"Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies","volume":"13","author":"Barber","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"2024120321073193800_zwae375-B25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"2024120321073193800_zwae375-B26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"2024120321073193800_zwae375-B27","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"key":"2024120321073193800_zwae375-B28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/09513590.2014.974535","article-title":"Pregnancy complications in polycystic ovary syndrome patients","volume":"31","author":"Katulski","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2024120321073193800_zwae375-B29","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1210\/jc.2018-02313","article-title":"Distinctive reproductive phenotypes in peripubertal girls at risk for polycystic ovary syndrome","volume":"104","author":"Torchen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024120321073193800_zwae375-B30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2008.05.018","article-title":"Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study","volume":"92","author":"Battaglia","year":"2009","journal-title":"Fertil Steril"},{"key":"2024120321073193800_zwae375-B31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/eurjpc\/zwae115","article-title":"Women\u2019s cardiovascular health prevention: are we ready to change the road?","volume":"31","author":"Castelvecchio","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2024120321073193800_zwae375-B32","doi-asserted-by":"crossref","first-page":"101576","DOI":"10.1016\/j.beem.2021.101576","article-title":"Hormone therapy and cardiovascular disease: benefits and harms","volume":"35","author":"Maas","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2024120321073193800_zwae375-B33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024120321073193800_zwae375-B34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2024120321073193800_zwae375-B35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12933-019-0860-y","article-title":"Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management","volume":"18","author":"Luo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024120321073193800_zwae375-B36","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.123.065827","article-title":"Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury","volume":"148","author":"Gao","year":"2023","journal-title":"Circulation"},{"key":"2024120321073193800_zwae375-B37","doi-asserted-by":"crossref","first-page":"950831","DOI":"10.3389\/fphar.2022.950831","article-title":"Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"2024120321073193800_zwae375-B38","doi-asserted-by":"crossref","first-page":"e22488","DOI":"10.1096\/fj.202200156RR","article-title":"DCBLD2 regulates vascular hyperplasia by modulating the platelet derived growth factor receptor-\u03b2 endocytosis through caveolin-1 in vascular smooth muscle cells","volume":"36","author":"Wang","year":"2022","journal-title":"FASEB J"},{"key":"2024120321073193800_zwae375-B39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/cac2.12495","article-title":"CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway","volume":"43","author":"Chen","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"2024120321073193800_zwae375-B40","doi-asserted-by":"crossref","first-page":"669285","DOI":"10.3389\/fcell.2021.669285","article-title":"DCBLD2 affects the development of colorectal cancer via EMT and angiogenesis and modulates 5-FU drug resistance","volume":"9","author":"Xie","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024120321073193800_zwae375-B41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/1541-7786.MCR-07-0142","article-title":"Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion","volume":"6","author":"Kim","year":"2008","journal-title":"Mol Cancer Res"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae375\/60922193\/zwae375.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae375\/60922193\/zwae375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:07:58Z","timestamp":1733242078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwae375\/7905166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae375","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"article-number":"zwae375"}}